Clinical Trial Update: Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating weekly cisplatin or nedaplatin given concurrently with intensity-modulated radiation therapy for nasopharyngeal carcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Nedaplatin (nedaplatin)

Snippet

Sponsor: He Xia | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: UNKNOWN